(nTMS) can be used for preoperative planning in brain tumor patients. Just recently, it has
been proven to actually change outcomes by increasing the rate of gross total resection
(GTR) and by reducing the surgery-related rate of paresis significantly in cohorts of patients
suffering from different entities of intracranial lesions. Yet, we also need data that shows
whether these changes also lead to a changed clinical course, and can also be achieved …